131 related articles for article (PubMed ID: 24042472)
21. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.
Ueo H; Motohashi H; Katsura T; Inui K
Biochem Pharmacol; 2005 Oct; 70(7):1104-13. PubMed ID: 16098483
[TBL] [Abstract][Full Text] [Related]
22. Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.
Ikemura K; Hamada Y; Kaya C; Enokiya T; Muraki Y; Nakahara H; Fujimoto H; Kobayashi T; Iwamoto T; Okuda M
Drug Metab Dispos; 2016 Oct; 44(10):1543-9. PubMed ID: 27465369
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
[TBL] [Abstract][Full Text] [Related]
24. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
[TBL] [Abstract][Full Text] [Related]
26. Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.
Watanabe H; Sakaguchi Y; Sugimoto R; Kaneko K; Iwata H; Kotani S; Nakajima M; Ishima Y; Otagiri M; Maruyama T
Clin Exp Nephrol; 2014 Oct; 18(5):814-20. PubMed ID: 24185403
[TBL] [Abstract][Full Text] [Related]
27. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
28. Time-Dependent Inhibition of hOAT1 and hOAT3 by Anthraquinones.
Ma L; Qin Y; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
Biol Pharm Bull; 2015; 38(7):992-5. PubMed ID: 26133709
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3).
Honjo H; Uwai Y; Iwamoto K
Drug Metab Lett; 2011 Apr; 5(2):140-37. PubMed ID: 21457143
[TBL] [Abstract][Full Text] [Related]
30. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
31. Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters.
Bakhiya N; Stephani M; Bahn A; Ugele B; Seidel A; Burckhardt G; Glatt H
J Am Soc Nephrol; 2006 May; 17(5):1414-21. PubMed ID: 16597690
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
[TBL] [Abstract][Full Text] [Related]
33. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
34. Characterization of uremic toxin transport by organic anion transporters in the kidney.
Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
[TBL] [Abstract][Full Text] [Related]
35. Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors.
Cihlar T; Ray AS; Laflamme G; Vela JE; Tong L; Fuller MD; Roy A; Rhodes GR
Antivir Ther; 2007; 12(2):267-72. PubMed ID: 17503669
[TBL] [Abstract][Full Text] [Related]
36. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
[TBL] [Abstract][Full Text] [Related]
37. Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization.
Duan P; Li S; Ai N; Hu L; Welsh WJ; You G
Mol Pharm; 2012 Nov; 9(11):3340-6. PubMed ID: 22973893
[TBL] [Abstract][Full Text] [Related]
38. Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen).
Wang L; Sweet DH
Drug Metab Pharmacokinet; 2013; 28(3):220-8. PubMed ID: 23229784
[TBL] [Abstract][Full Text] [Related]
39. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798
[TBL] [Abstract][Full Text] [Related]
40. Transport of xanthurenic acid by rat/human organic anion transporters OAT1 and OAT3.
Uwai Y; Honjo E
Biosci Biotechnol Biochem; 2013; 77(7):1517-21. PubMed ID: 23832370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]